Congress Urges Medicare to Monitor Use of AI in Prior Authorization
Summary
In a letter to the Centers for Medicare & Medicaid Services (CMS), more than 50 lawmakers in both the House and Senate expressed concern that Medicare Advantage plans are using AI in a way that results in denying care erroneously and contradicting provider assessment findings. They urge CMS to proactively monitor plan use of AI-driven tools and require a higher burden of proof for denying coverage of care when AI is used.
Impacted Sectors
© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.